CBD for Chronic Pain Doesn’t Work, Large Review Finds

[ad_1]

CBD for your chronic pain can be dangerous, the authors of a major review say. They found little evidence from clinical trials that CBD could be effective in treating severe pain. These products also tend to have incorrect information about the amount of CBD they contain or other unknown ingredients that can be dangerous for users, he adds.

CBD is short for cannabidiol, one of the two main components of marijuana (the other is delta-9-tetrahydrocannabinol, or THC, which gives the drug its high). CBD and other cannabinoids have legitimate medical uses. In 2018, for example, the product made with CBD Epidiolex was to be approved and the Food and Drug Administration for the treatment of certain types of epilepsy. And there has been a lot of research showing that CBD can be used to treat a variety of ailments, including anxiety, schizophrenia, opioid use disorder, and chronic pain. But not all CBD studies have been positive, and there are many claims about its benefits that have weak scientific support.

This new study, led by researchers from the University of Bath in the UK, reviewed data from randomized and controlled trials—often considered the gold standard of clinical evidence—testing CBD in different ways (head, mouth, under the tongue) for chronic pain. . All but one of these studies found that CBD was no better at reducing pain than a placebo.

The authors also found evidence from other studies and reviews that CBD products are often mislabeled, containing less or more CBD than advertised or sometimes containing other substances that may be harmful or illegal for users, such as THC. And while these impurities may not appear in products intended for medical use, today’s consumers often find CBD products from stores or online stores. Another study has also done it he encouraged that long-term or long-term use of CBD may not be harmful, possibly increasing the risk of liver damage.

“There is no good reason to think that CBD reduces pain, but there are good reasons to doubt the content of CBD products in terms of CBD content and purity,” the authors say in their paper. printed in the April issue of Journal of Pain.

CBD has been a buzzword business for years, with an iffy buzzword fad medicine. And while there is a chance that CBD could have a place in our medicine cabinets, the authors say that health regulators need to do more to stop the ambassadors who sell it as a cure for everything under the sun. They realize that people who take CBD for their pain often want all the help they can get, making them easy targets for snake oil salesmen.

“For many people with chronic pain, there is no medication that will relieve their pain. Chronic pain can be dangerous, so people are strongly encouraged to find pain relief in any way possible. This makes them vulnerable to the wild promises of CBD,” said study author and pain researcher Andrew Moore, in a words from the University of Bath.

In the US, the FDA has gone after some manufacturers and suppliers of CBD products for manufacturing unobserved obesity. And last year, the organization he said that a “new CBD regulatory framework” is needed to manage how these products are to be offered to consumers—a process that he intends to create with the help of Congress.

More information: Scientists Had High Volunteers to See How CBD and THC Affect the Brain Differently

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *